Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 26, 1982
Plasma lecithin-cholesterol acyltransferase activities in uraemic patientsM K Chan, L Ramdial, Z Varghese, et al.
Oncotarget|March 14, 2024
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cellsBenigno C Valdez, Bin Yuan, David Murray, et al.
Blood Advances|January 25, 2023
Outcomes of breakthrough COVID-19 infections in patients with hematologic malignanciesKelly S Chien, Christine B Peterson, Elliana Young, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 21, 2025
Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant RecipientsFareed Khawaja, Terri Lynn Shigle, Layale Yaghi, et al.
Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Transplantation and Cellular Therapy|March 2, 2024
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell LymphomaMuhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, et al.
Frontiers in Immunology|May 17, 2021
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 PatientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Leukemia|March 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamidePortia Smallbone, Kai Cao, Rima M Saliba, et al.
Pageof 3